Drugs / Low Dose Naltrexone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05363514 | Jul 2026 → Jun 2029 expected | postural orthostatic tachycardia syndrome | University of Calgary | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low Dose Naltrexone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05363514 ↗ |
| Route | Oral | “Participant takes Low Dose Naltrexone 4.5mg PO OD for 120 days.” NCT05363514 ↗ |